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Abstract 
Objective: To test the reliability and validity of using the Borg rating of 
perceived exertion (RPE) scale (ratings 6–20) in persons with multiple 
sclerosis (PwMS). 
Design: Nonrandomized repeated measures. 
Setting: Research laboratory. 
Participants: Volunteer sample (N=27) comprised of 16 PwMS (10 women) 
and 11 age-matched persons without multiple sclerosis (MS) (6 women). 
Clinical measures included symptomatic fatigue, depression, and MS 
functional capacity. 
Interventions: A submaximal cycling test was performed to estimate 
maximal capacity. Participants then pedaled for 2 minutes at 50% and 60% 
of predicted maximal oxygen consumption per unit time (V̇Ο2), and 
physiological measures and RPE were obtained (week 1: response protocol). 
One week later, participants replicated the prescribed V̇Ο2 using the RPE 
range from week 1 (week 2: reproduction protocol). V̇Ο2, heart rate, and 
respiratory quotient were measured continuously; RPE and workload were 
measured every minute; and blood lactate and mean arterial pressure were 
measured after exercise. 
Main Outcome Measures: RPE, workload, V̇Ο2, and heart rate from week 1 
to week 2. 
Results: PwMS had greater fatigue (P<.01) and disability (P  <.001). 
Baseline measures were similar between groups and weeks. During exercise, 
RPE, workload, (V̇Ο2, and heart rate were similar between groups. Both 
groups had an intraclass correlation coefficient >.86 for RPE, workload, and  
V̇Ο2. The intraclass correlation coefficient was comparatively lower for heart 
rate for both groups (MS group: .72, non-MS group: .83). RPE was highly 
correlated with V̇Ο2 (r=.691, P<.001) and workload (r=.700, P<.001) for the 
MS group. 
Conclusions: Results suggest that RPE can be reliably reproduced, is valid, 
and may be used in exercise prescription in mildly to moderately impaired 
PwMS during cycling exercise. 
Keywords: Exercise; Multiple sclerosis; Physical exertion; Rehabilitation 
List of abbreviations 
 MAP, mean arterial pressure;  
 MS, multiple sclerosis;  
 MSFC, Multiple Sclerosis Functional Composite;  
 PwMS, persons with multiple sclerosis;  
 RPE, rating of perceived exertion;  
 RQ, respiratory quotient;  
 V̇Ο2, oxygen consumption per unit time 
Multiple sclerosis (MS) is an autoimmune disease of the central 
nervous system which often causes sensory, motor, and autonomic 
impairment and leads to fatigue, weakness, and decreased physical 
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activity.1, 2 and 3 Exercise for persons with multiple sclerosis (PwMS) was 
once contraindicated.4 and 5 Now, evidence supports the use of exercise 
in PwMS to improve muscle strength,6, 7 and 8 cardiorespiratory 
function,9 and 10 quality of life,8, 9, 11 and 12 depression,9, 12 and 13 and 
fatigue.9, 11 and 14 Therefore, it is important to develop safe and effective 
exercise prescriptions and recommendations for PwMS. 
Exercise intensity is a key component of exercise prescription15 
and often is prescribed with a training heart rate range. In many 
fitness settings, a submaximal aerobic test, if any at all, is used to 
determine a training heart rate range.16 Submaximal tests rely on an 
approximation of maximal heart rate, but alterations in cardiovascular 
autonomic control in some PwMS may lead to error in heart rate 
approximations.17, 18, 19 and 20 This may limit the use of heart rate as an 
indicator of exercise intensity in some PwMS. In addition, heart rate 
can be altered by factors including exercise mode, posture, 
temperature, drugs, and anxiety.21 Many of these factors can be 
altered in PwMS, which could limit the use of heart rate for exercise 
prescription in PwMS. 
Ratings of perceived exertion (RPEs) have been recommended 
to monitor exercise intensity in PwMS.1, 22 and 23 The RPE is mediated by 
physiological and psychological factors, performance settings, and 
exertional symptoms.24 The RPE has been used successfully in many 
populations24 and is endorsed for monitoring exercise intensity.15 
Because the RPE is mediated by aspects of exercise in addition to 
heart rate,24 it may overcome potential issues with using heart rate for 
exercise prescription in PwMS or represent an alternative or 
complementary approach. 
Systematic (validity) and random error (reliability) of using the 
RPE in PwMS may be affected by some of the same factors that might 
make heart rate unsuitable for exercise prescription. Increased central 
neural drive,25 and 26 symptomatic fatigue,4 and 27 depression,28 and 
impaired sensory feedback29 or integration30 in PwMS may affect the 
validity of using the RPE in this population. In addition, greater 
variability exists in PwMS compared with people without MS for 
depression,31 fatigue,27 information processing,32 and other factors that 
could affect the RPE. This greater variability may affect the reliability 
of the RPE in PwMS. 
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Nevertheless, the RPE can be similar in PwMS and people 
without MS during incremental dynamic exercise to task failure33 and 
during submaximal isometric exercise.34 These earlier studies provide 
initial validation of the RPE in PwMS. However, little is known about 
the validity of the RPE during submaximal dynamic exercise, which is 
typically prescribed for health and fitness. Importantly, it also is not 
known if the RPE in PwMS is reproducible, which is necessary for 
validity. If the physiological exercise-related processes associated with 
the RPE are shown to be reliable and valid in PwMS during submaximal 
aerobic exercise, then the RPE could be a valuable tool for exercise 
prescription and monitoring. 
Therefore, the purpose of this study was to test the reliability 
and validity of the Borg RPE scale (ratings 6–20) during submaximal 
aerobic exercise at a given exercise intensity in PwMS. To achieve 
some degree of ecologic validity, we determined this exercise intensity 
using standard techniques and estimated relative intensities that might 
be used in a fitness setting. 
Methods 
Participants were tested over 2 visits separated by 6 to 10 days. 
During the first visit, participants underwent a submaximal exercise 
test, performed cycling at 50% and 60% of their predicted maximal 
effort (response protocol), and practiced reproducing the associated 
RPE (production protocol). During the second visit, participants 
reproduced the effort from week 1 by matching the same RPE range 
(reproduction protocol). Testing was performed at 50% to 60% of 
maximal effort to provide flexibility in the exertion level but maintain 
the ability to compare responses between weeks. Exercise was 
performed on an electrically braked cycle ergometer (VIAsprint 150Pa) 
at 60±3 revolutions per minute. Questionnaires and baseline 
physiological measurements were collected prior to exercise each 
week. 
Participants 
Participants were initially recruited through advertisements from 
the Wisconsin chapter of the National Multiple Sclerosis Society. We 
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also recruited participants who matched our inclusion criteria from a 
pool of individuals from unrelated studies. All participants were 
nonsmokers; had no other major neurologic, metabolic, or 
cardiovascular diseases; did not use cardiovascular drugs (eg, beta-
blockers); and were not in a concurrent clinical drug trial. Control 
participants were recruited to have a similar mean age and sex 
composition. All participants provided written informed consent, 
approved by the Marquette University Institutional Review Board. 
Sample size was determined to achieve precise estimates of reliability 
(confidence interval width, 0.2), with an intraclass correlation 
coefficient of 0.9.35 
Questionnaires 
Prior to exercise testing each week, participants completed 
questionnaires to assess symptomatic fatigue and depressive 
symptoms. Symptomatic fatigue was measured with the Modified 
Fatigue Impact Scale,36, 37 and 38 and depressive symptoms were 
measured with the Center for Epidemiologic Studies–Depression 
Scale.39 and 40 Participants also reported recent caffeine consumption, 
hours of sleep the prior night, and recent physical activity. PwMS 
reported the last date of any disease-modifying therapy. For the 
second visit, participants were instructed to replicate their levels of 
caffeine consumption, sleep, and physical activity and maintain a 
similar therapy regimen. No participants showed noticeable deviations 
in these measures from week 1 to week 2. 
Disability 
All participants completed the Multiple Sclerosis Functional 
Composite (MSFC), a measure of global function consisting of the 
timed 25-foot walk, 9-hole peg test, and Paced Auditory Serial 
Addition Task.41 and 42 Scores from each component were presented 
individually and were transformed into a z score based on a 
representative database of PwMS. 43 
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Baseline measures 
Prior to exercise, baseline measures were obtained with 
participants seated on the cycle ergometer and included the following: 
oxygen consumption per unit time (V̇Ο2) and respiratory quotient (RQ) 
obtained continuously with open circuit spirometry (Vmax Encorea) and 
calibrated prior to each experimental session; heart rate measured 
from a heart rate monitor (Polar T31b); blood lactate obtained with a 
finger prick (Lactate Proc); and brachial artery pressure measured by 
manual sphygmomanometry. Blood pressure is presented as mean 
arterial pressure (MAP) (diastolic pressure + [1/3 × pulse pressure]). 
Participants were oriented to and taught how to use the Borg RPE 
scale (ratings 6–20) as previously described.24 Orientation included 
verbal and mental anchoring to the range of exertion on the scale.24 
Submaximal test 
Participants underwent a submaximal Young Men's Christian 
Association test after performing a 3-minute warm-up at 25W.44 
Maximal V̇Ο2 was predicted by linear extrapolation of  
V̇Ο2 and heart rate to age-predicted maximal heart rate.
15 Intensity 
levels for exercise testing were determined as a percentage of 
predicted maximal V̇Ο2 levels. V̇Ο2 and heart rate were measured 
continuously, RPE and workload were measured every minute, and 
blood pressure was obtained at the end of each stage. Each 
submaximal test lasted approximately 10 minutes. 
Response protocol 
The RPE range associated with a range of exercise intensities 
was determined. Participants rested after the submaximal test until 
heart rate and MAP returned to baseline levels and then exercised at 
50% and 60% of their predicted maximal V̇Ο2. Two minutes of cycling 
was performed at each intensity level with no warm-up period. 
Workloads were set by the investigators, and participants were blinded 
to this workload. Participants provided RPEs twice for each workload 
and were instructed to internalize the sensations associated with this 
RPE range. V̇Ο2, heart rate, and RQ were continuously measured, and 
the RPE and workload were recorded every minute. Blood pressure 
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was obtained during the last minute of exercise, and lactate was 
measured within 1 minute of the termination of exercise. 
Production protocol 
Next, participants practiced reproducing the effort level from the 
response protocol to acquaint them with the procedure for the second 
visit. Participants rested until heart rate and MAP recovered to baseline 
and then pedaled for 4 minutes within the RPE range they experienced 
during the response protocol.21 Blinding was performed, and initial 
workload was randomly chosen to be 5 to 15W higher or lower than 
the workload range from the response protocol. Participants were 
instructed to adjust the resistance to maintain an effort that was 
within the target RPE range and were encouraged to maintain the 
desired effort. RPE, V̇Ο2, heart rate, RQ, lactate, and blood pressure 
were all collected as during the response protocol. 
Reproduction protocol 
Then 6 to 10 days later, participants reproduced the effort level 
from week 1. After a 3-minute warmup at approximately 25W, 
participants pedaled for 4 minutes and reproduced the RPE range 
associated with their training range (50%–60% of the estimated 
maximal V̇Ο2) from the first visit. Blinding was again performed. 
Participants were instructed to adjust the resistance to achieve this 
RPE range. RPE, workload, V̇Ο2, heart rate, RQ, lactate, and blood 
pressure were measured in the same manner as during week 1. 
Analysis 
Repeated-measures analysis of variance was used to compare 
physiological measures obtained during exercise, resting physiological 
variables, and questionnaire data from week 1 (response protocol) 
with week 2 (reproduction protocol) for PwMS and the non-MS group. 
Intraclass correlation coefficients model 2,1 were obtained to assess 
the reliability of the RPEs and other physiological measures across 
weeks.45 For the response and reproduction protocol, Pearson 
correlations were performed between the RPE and measured 
physiological variables as an indication of convergent validity. These 
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correlations were then transformed to Fisher z scale, averaged, and 
inverse transformed (average estimate). Student t tests were used to 
compare subject characteristics, MSFC scores, and predicted maximal 
values between the MS and non-MS groups. Data were analyzed using 
SPSS Statistics 22.0. d Significance was accepted at P≤.05. 
Results 
Participant characteristics 
Sixteen participants with MS (10 women; Expanded Disability 
Status Scale score median, 1.75; range, 1–5) were compared with 11 
participants without MS (6 women) (table 1). Disease courses for the 
MS group were relapsing-remitting (n=9), progressive (n=5), and 
unknown (n=2). The MS and non-MS groups were similar in age, 
height, and mass. The MSFC z score was lower in the MS group 
compared with the non-MS group. Correspondingly, the timed 25-foot 
walk and 9-hole peg test were slower, and the Paced Auditory Serial 
Addition Test score was lower in the MS group. 
Table 1. Subject characteristics 
Variables MS Group Non-MS Group 95% CI P 
Years since diagnosis 5.5 (1–20)    
Age (y) 45.7±4.9 42.9±7.5 −2.1 to 7.7 .254 
Mass (kg) 72.9±18.3 74.6±14.4 −15.3 to 12.0 .804 
Height (m) 1.69±0.12 1.73±0.11 −0.13 to 0.06 .451 
MSFC z score 0.27±0.53 1.01±0.26 −1.1 to −0.39 <.001∗ 
Timed 25-foot walk (s) 4.62±1.77 3.38±0.65 0.08 to 2.40 .037∗ 
9-hole peg test (s) 21.4±4.3 17.0±2.0 1.5 to 7.3 .004∗ 
PASAT 43.9±15.2 56.1±2.9 −20.4 to −3.9 .006∗ 
NOTE. Values are mean ± SD, mean (range), or as otherwise indicated. 
Abbreviations: CI, confidence interval; PASAT, Paced Auditory Serial Addition Test. 
∗P<.05. 
Baseline measures 
There were no group, time, or group×time effects for baseline 
RPE, V̇Ο2, heart rate, RQ, lactate, and MAP (table 2). Baseline fatigue 
was greater, and there was a trend for greater depression in the MS 
group, but fatigue and depression levels were consistent between 
weeks. Room temperature and humidity were not different between 
weeks; however, room temperature was lower in the MS group. 
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Table 2. Preexercise baseline variables 
Variables Group Week 1 Week 2 
Main Effects, P 
 
Interaction, P 
V̇Ο2 (L/min) 
MS 0.28±0.10 0.32±0.12 Group .99  
Non-MS 0.30±0.08 0.31±0.08 Time .16 .33 
V̇Ο2 (mL/kg/min) 
MS 3.9±0.9 4.5±1.6 Group .83  
Non-MS 4.0±0.9 4.2±1.2 Time .14 .37 
HR (beats/min) 
MS 69.1±15.0 73.3±15.1 Group .38  
Non-MS 74.7±12.0 76.5±6.5 Time .10 .48 
MAP (mmHg) 
MS 90.1±7.5 90.3±8.3 Group .88  
Non-MS 89.9±8.0 89.6±6.3 Time .97 .88 
RQ 
MS 0.84±0.09 0.82±0.12 Group .95  
Non-MS 0.83±0.06 0.82±0.14 Time .50 .68 
Lactate (mmol/L) 
MS 2.9±2.6 1.9±0.5 Group .65  
Non-MS 2.1±0.8 2.2±1.1 Time .24 .21 
CES-D 
MS 7.7±10.0 8.5±10.0 Group .06∗  
Non-MS 2.1±2.0 2.7±3.0 Time .49 .94 
MFIS 
MS 29.2±22.9 29.1±22.6 Group <.001†  
Non-MS 4.2±6.3 3.9±5.2 Time .86 .95 
Room temperature (°C) 
MS 21.7±1.0 22.0±1.1 Group .03†  
Non-MS 22.9±1.9 22.9±1.8 Time .37 .55 
Room humidity (%) 
MS 36.8±11.5 33.4±11.6 Group .06  
Non-MS 43.7±12.1 43.9±10.1 Time .15 .11 
NOTE. Values are mean ± SD or as otherwise indicated. 
Abbreviations: CESD, Center for Epidemiologic Studies Depression Scale; HR, heart 
rate; MFIS, Modified Fatigue Impact Scale. 
∗Trend for significance. 
†P<.05. 
Submaximal test 
The Young Men's Christian Association test produced similar predicted 
maximal workload, V̇Ο2, and heart rate in the MS and non-MS groups 
(table 3). The lack of difference between groups highlights that the MS 
group was only mildly to moderately impaired. 
Table 3. Predicted maximal levels 
Variables MS Group Non-MS Group 95% CI P 
V̇Ο2 (mL/kg/min) 37.4±13.5 35.4±10.3 −7.9 to 11.9 .684 
Workload 178.4±84.3 184.4±62.4 −67 to 56 .844 
HR (beats/min) 174.3±4.91 177.1±7.5 −7.7 to 2.1 .254 
NOTE. Values are mean ± SD or as otherwise indicated. 
Abbreviations: CI, confidence interval; HR, heart rate. 
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Exercise measurements 
Repeated-measures analysis of variance indicated no group (MS 
group vs non-MS group), time (week 1 vs week 2), or group×time 
effects for RPE, workload, V̇Ο2, or MAP (fig 1). Heart rate decreased 
from week 1 to week 2 (P=.015), but decreased similarly in both 
groups. RQ increased in both groups from week 1 to week 2 (P<.001), 
with a greater increase in the MS group (P=.008). All participants 
remained within the prescribed target training range based on the RPE 
during week 2 (reproduction protocol). Exercise physiological variables 
were similar among different MS disease types (data not shown, 
P>.05). 
 
Fig 1.  Responses to a prescribed RPE training range. Gray lines indicate individual 
data, whereas black lines represent group averages. Values displayed in the figure are 
average values for the indicated group. Abbreviation: HR, heart rate. 
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RPE reliability 
Table 4 indicates moderate to high reliability for key exercise 
variables for both MS and non-MS groups. Heart rate showed 
moderate reliability in both groups. In contrast, reliability for RQ and 
lactate were comparatively weak for both groups. Bland-Altman plots 
(fig 2) do not reveal any systematic biases. For RPE and other 
physiological measures, the average difference value is near 0, 
indicating reliable and agreeable measurements. 
Table 4. ICCs between weeks 1 and 2 
Variables ICC 95% CI P 
MS group 
 RPE .870 .668 to .953 <.001∗ 
 Workload (W) .862 .650 to .949 <.001∗ 
 V̇Ο2 (L/min) .925 .799 to .973 <.001∗ 
 V̇Ο2 (mL/kg/min) .850 .623 to .945 <.001∗ 
 HR (bpm) .716 .357 to .891 .001∗ 
 RQ .555 .100 to .818 .010∗ 
 Lactate (mmol/L) .521 .052 to .802 .016∗ 
 MAP (mmHg) .842 .577 to .946 <.001∗ 
Non-MS group 
 RPE .938 .788 to .983 <.001∗ 
 Workload (W) .962 .865 to .990 <.001∗ 
 V̇Ο2 (L/min) .970 .894 to .992 <.001∗ 
 V̇Ο2 (mL/kg/min) .954 .839 to .987 <.001∗ 
 HR (bpm) .827 .481 to .950 <.001∗ 
 RQ .754 .314 to .927 .001∗ 
 Lactate (mmol/L) .205 −.421 to .699 .261 
 MAP (mmHg) .871 .592 to .964 <.001∗ 
Abbreviations: bpm, beats per minute; CI, confidence interval; HR, heart rate; ICC, 
intraclass correlation coefficient. 
∗P<.05. 
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Fig 2. Bland-Altman plots of differences in RPE and exercise responses between week 
1 and week 2. The solid dashed line represents the average difference value, whereas 
the top and bottom dashed lines represent 2 SD above and below the mean difference 
value, respectively. Triangles represent individual participants with MS, and the circles 
represent participants without MS. Abbreviation: HR, heart rate. 
Convergent validity 
Table 5 demonstrates that high correlations (convergent 
validity) were found between the RPE and workload and V˙o2 for 
both the MS and non-MS groups (criterion validity). In the non-MS 
group, the RPE also showed high correlations with RQ and MAP. 
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Table 5. Pearson correlations between physiological variables and RPE 
Variables Correlation With RPE 
 
 
Week 1 Week 2 Average Estimate 
MS group 
 Workload (W) .720∗ .674∗ .700 
 V̇Ο2 (L/min) .723∗ .660∗ .691 
 V̇Ο2 (mL/kg/min) .476 .536∗ .507 
 HR (bpm) −.336 −.225 −.282 
 RQ .069 −.048 .019 
 Lactate (mmol/L) −.476 .174 −.168 
 MAP (mmHg) .121 .303 .211 
Non-MS group 
 Workload (W) .596 .558 .581 
 V̇Ο2 (L/min) .642∗ .575 .613 
 V̇Ο2 (mL/kg/min) .608∗ .506 .566 
 HR (bpm) −.379 −.058 −.219 
 RQ .405 .562 .476 
 Lactate (mmol/L) .235 −.012 .114 
 MAP (mmHg) .789∗ .627∗ .717 
Abbreviations: bpm, beats per minute; HR, heart rate. 
∗P<.05 for within-week correlations. 
Discussion 
To our knowledge, this study demonstrates for the first time 
that the Borg RPE scale (ratings 6–20) is reliable over 1 week in 
persons with mild to moderate MS during submaximal cycling exercise. 
RPE, workload, V̇Ο2, and MAP were all similar between weeks 1 and 2. 
Furthermore, these variables all had high intraclass correlations, 
suggesting that individual participants had similar RPEs (and other 
physiological measures) between weeks. Taken together, this suggests 
that key indicators of exercise intensity, including the RPE, were 
reproducible across 1 week. 
This study also provides additional insight into the construct 
validity of the RPE in PwMS. The high positive correlations in PwMS 
between the RPE, V̇Ο2, and workload are what would be expected if the 
RPE was linear and perceptually mediated by V̇Ο2 and workload, as in 
persons without MS.34 That heart rate correlated poorly with the RPE is 
consistent with heart rate being a mediating but not primary factor in 
determining the perceptual response to effort.24 Blood lactate also 
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poorly correlated with the RPE, but it is not thought to be linear with 
the RPE until concentrations are above the lactate threshold. The low 
mean RPE suggests that lactate concentrations were below this 
threshold.24 The low correlation between the RPE and MAP in the MS 
group may reflect issues with cardiovascular autonomic control17, 18, 19, 
20 and 24 and confirms that MAP is not a primary mediator of the RPE.24 
Finally, PwMS may have had saturated RQ values, resulting in a low 
correlation with the RPE. 
This study extends the findings of Morrison et al,33 which 
demonstrated that the RPE is similar between persons with mild MS 
and people without MS during incremental cycling exercise. A similar 
result has been shown during sustained submaximal isometric 
contractions.34 In contrast, Thickbroom et al26 showed an exaggerated 
RPE in PwMS during isometric exercise compared with a non-MS 
group. Our findings may differ because Thickbroom had participants 
perform intermittent isometric contractions with a hand muscle, 
whereas our study used a lower-limb cycling protocol.26 In this 
previous study, PwMS had a faster rate of increase in the RPE, but 
experienced similar relative muscle fatigue as people without MS. 
Therefore, PwMS may be less accurate when estimating exertion for a 
small muscle group. Overall, the literature appears to support the 
validity of the RPE in PwMS, at least during cycling exercise. By 
demonstrating reliability and further contributing to the validity of the 
RPE, we provide credible evidence for recommendations to use the RPE 
to monitor exercise intensity during aerobic exercise in PwMS.1, 22 and 23 
Caution has been advised in using heart rate for exercise 
prescription in PwMS because potential cardiovascular autonomic 
impairment may lead to a blunted cardiovascular response46 and 47; 
however, this is controversial.34 Our results do not necessarily support 
this concern because heart rate–based measures, including response 
to exercise, were similar in MS and non-MS groups. However, our 
results do not preclude individual altered cardiovascular regulation in 
PwMS as has been reported,17, 18, 19, 20, 34 and 48 and individual 
assessment should take precedence in any exercise setting. 
A submaximal exercise test was used as an initial method to 
determine exercise intensities and simulate an exercise prescription 
that might be encountered in a community health, fitness, or wellness 
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setting.15 and 16 Although submaximal exercise tests have limitations, 
the primary aim of this study was to determine whether a prescribed 
exercise response associated with a RPE is reproducible and valid 
based on the RPE. All measured values were within recommended 
levels for exercise in PwMS, including the RPE (12.5).15 and 23 
Fatigue, depression, and disease status were stable across test 
sessions. Therefore, the validity of the RPEs in PwMS during a relapse 
or otherwise nonstable phase of disease cannot be determined from 
this study. One potential advantage of using the RPE to monitor 
exercise intensity in a symptom-limited population is that the RPE is 
independent of absolute work level and can be adjusted relative to 
physiological state (eg, disease, sickness, environment). For example, 
under symptom exacerbation, the absolute exercise workload may be 
appropriately lower at a similar target RPE. It is important that the use 
of the RPE under nonstable conditions be described systematically in 
future studies. 
Study limitations 
The small number of participants in our study suggests that our 
results should be considered of a pilot nature and interpreted with 
care. As discussed, some have suggested that caution must be taken 
when using submaximal data for predicting maximal V̇Ο2.
46 Therefore, 
a limitation is that we did not perform maximal V̇Ο2 tests; however, 
predicted values were consistent with what others have observed.46 
More importantly, the actual V̇Ο2 for the 2 exercise sessions was 
reproducible and similar between groups. The room temperature for 
PwMS was lower compared with people without MS. This difference in 
temperature likely did not affect the reliability of the RPE because 
temperature was similar between weeks for each group. All PwMS 
tested were ambulatory and mildly to moderately impaired. 
Consequently, our results should not be extrapolated to those who are 
more seriously impaired. Finally, we do not know if our results can be 
extrapolated to different exercise intensities, durations, or modes. 
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Conclusions 
These preliminary findings indicate that the Borg scale (ratings 
6–20) can be reproducible over a week and are valid in persons with 
mild to moderate MS. Therefore, the RPE may be a reliable and valid 
method of monitoring and prescribing exercise intensity in PwMS 
during cycling exercise. Exercise recommendations in an MS 
population must be based on individual responses. Further 
investigation is needed in this important area of exercise prescription 
in PwMS. 
Suppliers 
a. BD. 
b. Polar T31; Polar Electro. 
c. Lactate Pro; Arkray. 
d. SPSS Statistics 22.0; IBM. 
 
Acknowledgments 
We thank the Wisconsin Chapter of the National Multiple Sclerosis Society for 
their help with recruitment. We also thank Joshua Cowdy, BS, for his help 
with data collection. 
References 
1J. Myers, D.C. Nieman. American College of Sports Medicine. ACSM's 
resources for clinical exercise physiology: musculoskeletal, 
neuromuscular, neoplastic, immunologic, and hematologic conditions. 
(2nd ed.)Wolters Kluwer Health/Lippincott Williams & Wilkins Health, 
Philadelphia (2010) 
2R.W. Motl, E. McAuley, E.M. Snook. Physical activity and multiple sclerosis: a 
meta-analysis. Mult Scler, 11 (2005), pp. 459–463 
3A.V. Ng, J.A. Kent-Braun. Quantitation of lower physical activity in persons 
with multiple sclerosis. Med Sci Sports Exerc, 29 (1997), pp. 517–523 
4J.E. Freal, G.H. Kraft, J.K. Coryell. Symptomatic fatigue in multiple sclerosis. 
Arch Phys Med Rehabil, 65 (1984), pp. 135–138 
5G. Sutherland, M.B. Andersen. Exercise and multiple sclerosis: physiological, 
psychological, and quality of life issues. J Sports Med Phys Fitness, 41 
(2001), pp. 421–432 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Archives of Physical Medicine and Rehabilitation, Vol. 97, No. 6 (June 2016): pg. 974-982. DOI. This article is © Elsevier 
(WB Saunders) and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier (WB 
Saunders) does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Elsevier (WB Saunders). 
17 
 
6L.S. DeBolt, J.A. McCubbin. The effects of home-based resistance exercise on 
balance, power, and mobility in adults with multiple sclerosis. Arch 
Phys Med Rehabil, 85 (2004), pp. 290–297 
7L.J. White, S.C. McCoy, V. Castellano, et al. Resistance training improves 
strength and functional capacity in persons with multiple sclerosis. 
Mult Scler, 10 (2004), pp. 668–674 
8T.M. Cruickshank, A.R. Reyes, M.R. Ziman. A systematic review and meta-
analysis of strength training in individuals with multiple sclerosis or 
Parkinson disease. Medicine (Baltimore), 94 (2015), p. e411 
9J.H. Petajan, E. Gappmaier, A.T. White, M.K. Spencer, L. Mino, R.W. Hicks. 
Impact of aerobic training on fitness and quality of life in multiple 
sclerosis. Ann Neurol, 39 (1996), pp. 432–441 
10J.A. Ponichtera-Mulcare, T. Mathews, P.J. Barrett, S.C. Gupta. Change in 
aerobic fitness of patients with multiple sclerosis during a 6-month 
training program. Sports Med Train Rehabil, 7 (1997), pp. 265–272 
11S. Mostert, J. Kesselring. Effects of a short-term exercise training program 
on aerobic fitness, fatigue, health perception and activity level of 
subjects with multiple sclerosis. Mult Scler, 8 (2002), pp. 161–168 
12C. Swank, M. Thompson, A. Medley. Aerobic exercise in people with multiple 
sclerosis: its feasibility and secondary benefits. Int J MS Care, 15 
(2013), pp. 138–145 
13K. Rasova, E. Havrdova, P. Brandejsky, M. Zalisova, B. Foubikova, P. 
Martinkova. Comparison of the influence of different rehabilitation 
programmes on clinical, spirometric and spiroergometric parameters in 
patients with multiple sclerosis. Mult Scler, 12 (2006), pp. 227–234 
14G.M. Gehlsen, S.A. Grigsby, D.M. Winant. Effects of an aquatic fitness 
program on the muscular strength and endurance of patients with 
multiple sclerosis. Phys Ther, 64 (1984), pp. 653–657 
15L.S. Pescatello, R. Arena, American College of Sports Medicine, et al. 
ACSM's guidelines for exercise testing and prescription. (9th 
ed.)Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia 
(2014) 
16V. Noonan, E. Dean. Submaximal exercise testing: clinical application and 
interpretation. Phys Ther, 80 (2000), pp. 782–807 
17J.R. Anema, M.W. Heijenbrok, T.J. Faes, J.J. Heimans, P. Lanting, C.H. 
Polman. Cardiovascular autonomic function in multiple sclerosis. J 
Neurol Sci, 104 (1991), pp. 129–134 
18D.I. Gunal, N. Afsar, T. Tanridag, S. Aktan. Autonomic dysfunction in 
multiple sclerosis: correlation with disease-related parameters. Eur 
Neurol, 48 (2002), pp. 1–5 
19A.R. Acevedo, C. Nava, N. Arriada, A. Violante, T. Corona. Cardiovascular 
dysfunction in multiple sclerosis. Acta Neurol Scand, 101 (2000), pp. 
85–88 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Archives of Physical Medicine and Rehabilitation, Vol. 97, No. 6 (June 2016): pg. 974-982. DOI. This article is © Elsevier 
(WB Saunders) and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier (WB 
Saunders) does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Elsevier (WB Saunders). 
18 
 
20M.P. Senaratne, D. Carroll, K.G. Warren, T. Kappagoda. Evidence for 
cardiovascular autonomic nerve dysfunction in multiple sclerosis. J 
Neurol Neurosurg Psychiatry, 47 (1984), pp. 947–952 
21W.D. Russell. On the current status of rated perceived exertion. Percept Mot 
Skills, 84 (1997), pp. 799–808 
22J.L. Durstine. American College of Sports Medicine. ACSM's exercise 
management for persons with chronic diseases and disabilities. (3rd 
ed.)Human Kinetics, Champaign (2009) 
23L.J. White, R.H. Dressendorfer. Exercise and multiple sclerosis. Sports Med, 
34 (2004), pp. 1077–1100 
24B.J. Noble, R.J. Robertson. Perceived exertion. Human Kinetics, Champaign 
(1996) 
25A.V. Ng, R.G. Miller, J.A. Kent-Braun. Central motor drive is increased 
during voluntary muscle contractions in multiple sclerosis. Muscle 
Nerve, 20 (1997), pp. 1213–1218 
26G.W. Thickbroom, P. Sacco, A.G. Kermode, et al. Central motor drive and 
perception of effort during fatigue in multiple sclerosis. J Neurol, 253 
(2006), pp. 1048–1053 
27L.B. Krupp, L.A. Alvarez, N.G. LaRocca, L.C. Scheinberg. Fatigue in multiple 
sclerosis. Arch Neurol, 45 (1988), pp. 435–437 
28A. Feinstein. Multiple sclerosis and depression. Mult Scler, 17 (2011), pp. 
1276–1281 
29M.H. Cameron, F.B. Horak, R.R. Herndon, D. Bourdette. Imbalance in 
multiple sclerosis: a result of slowed spinal somatosensory conduction. 
Somatosens Mot Res, 25 (2008), pp. 113–122 
30C. Cabib, S. Llufriu, J. Casanova-Molla, A. Saiz, J. Valls-Solé. Defective 
sensorimotor integration in preparation for reaction time tasks in 
patients with multiple sclerosis. J Neurophysiol, 113 (2015), pp. 1462–
1469 
31M.H. Verdier-Taillefer, V. Gourlet, R. Fuhrer, A. Alpérovitch. Psychometric 
properties of the Center for Epidemiologic Studies-Depression scale in 
multiple sclerosis. Neuroepidemiology, 20 (2001), pp. 262–267 
32M. Wojtowicz, A. Omisade, J.D. Fisk. Indices of cognitive dysfunction in 
relapsing-remitting multiple sclerosis: intra-individual variability, 
processing speed, and attention network efficiency. J Int Neuropsychol 
Soc, 19 (2013), pp. 551–558 
33E.H. Morrison, D.M. Cooper, L.J. White, et al. Ratings of perceived exertion 
during aerobic exercise in multiple sclerosis. Arch Phys Med Rehabil, 
89 (2008), pp. 1570–1574 
34A.V. Ng, H.T. Dao, R.G. Miller, D.F. Gelinas, J.A. Kent-Braun. Blunted 
pressor and intramuscular metabolic responses to voluntary isometric 
exercise in multiple sclerosis. J Appl Physiol, 88 (2000), pp. 871–880 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Archives of Physical Medicine and Rehabilitation, Vol. 97, No. 6 (June 2016): pg. 974-982. DOI. This article is © Elsevier 
(WB Saunders) and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier (WB 
Saunders) does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Elsevier (WB Saunders). 
19 
 
35D.G. Bonett. Sample size requirements for estimating intraclass correlations 
with desired precision. Stat Med, 21 (2002), pp. 1331–1335 
36J.D. Fisk, P.G. Ritvo, L. Ross, D.A. Haase, T.J. Marrie, W.F. Schlech. 
Measuring the functional impact of fatigue: initial validation of the 
fatigue impact scale. Clin Infect Dis, 18 (Suppl 1) (1994), pp. S79–S83 
37R.A. Marrie, D.M. Miller, G.J. Chelune, J.A. Cohen. Validity and reliability of 
the MSQLI in cognitively impaired patients with multiple sclerosis. Mult 
Scler, 9 (2003), pp. 621–626 
38P.G. Ritvo, J.S. Fisher, D.M. Miller, A. Andrews, D.W. Paty, N.G. LaRocca. 
Multiple sclerosis quality of life inventory: a user's manual. National 
Multiple Sclerosis Society, New York (1997) 
39L.S. Radloff. The CES-D scale: a self-report depression scale for research in 
the general population. Appl Psychol Meas, 1 (1977), pp. 385–401 
40M.E. Maruish. The use of psychological testing for treatment planning and 
outcomes assessment. (3rd ed.)Lawrence Erlbaum Associates, 
Mahwah (2004) 
41G.R. Cutter, M.L. Baier, R.A. Rudick, et al. Development of a multiple 
sclerosis functional composite as a clinical trial outcome measure. 
Brain, 122 (1999), pp. 871–882 
42J.S. Fischer, R.A. Rudick, G.R. Cutter, S.C. Reingold. The Multiple Sclerosis 
Functional Composite Measure (MSFC): an integrated approach to MS 
clinical outcome assessment. National MS Society Clinical Outcomes 
Assessment Task Force. Mult Scler, 5 (1999), pp. 244–250 
43J.S. Fischer, A.J. Jak, J.E. Kniker, R.A. Rudick, G. Cutter. Multiple sclerosis 
functional composite (MSFC). Administration and scoring manual. 
National Multiple Sclerosis Society, New York (2001) 
44L.A. Golding, C.R. Myers. Y's Way to physical fitness: the complete guide to 
fitness testing and instruction. (3rd ed.)Human Kinetics, Champaign 
(1989) 
45W.J. Vincent, J.P. Weir. Statistics in kinesiology. (4th ed.)Human Kinetics, 
Champaign (2012) 
46J. Ponichtera-Mulcare, R. Glaser, T. Mathews, D. Camaione. Maximal aerobic 
exercise in persons with multiple sclerosis. Clinical Kinesiology, 46 
(1993), pp. 12–21 
47E.B. Pepin, R.W. Hicks, M.K. Spencer, Z.V. Tran, C.G. Jackson. Pressor 
response to isometric exercise in patients with multiple sclerosis. Med 
Sci Sports Exerc, 28 (1996), pp. 656–660 
48A.J. McDougall, J.G. McLeod. Autonomic nervous system function in multiple 
sclerosis. J Neurol Sci, 215 (2003), pp. 79–85 
 
Corresponding author Brice T. Cleland, MS, Department of Physical 
Therapy, Marquette University, PO Box 1881, Milwaukee, WI 53201-
1881. 
